Xbrane Biopharma Ab Is A Swedish Biotechnology Company Founded In 2008Specializing In The Developmentmanufactureand Sale Of Biosimilarsthese Are Affordable Alternatives To Biological Drugs That Have Lost Patent Protectionthe Company Was Established By Researchers From Stockholm University And Entrepreneurs Focused On Making Biological Drugs More Accessible Xbrane Utilizes A Patented Platform Technology That Enhances Productivity And Significantly Reduces Production Coststhis Technology Is Based On High Yield Protein Expression In Host Cellssuch As Ecolithe Company Has Developed Several Biosimilarsincluding Xlucane For Macular Degenerationbiib801 For Rheumatoid Arthritis And Psoriasisxdivane For Cancer Treatmentand Ximlucianother Treatment For Macular Degenerationadditionallyxbrane Offers Sperotidea Generic Version Of Certain Branded Drugs Initiallyxbrane Provided Technology Services To Pharmaceutical Companies But Shifted Its Focus In 2014 To Developing Its Own Biosimilarscapitalizing On The Market Potential From Expiring Patents On Large Biological Drugs
No conferences found for this company.
| Company Name | Xbrane Biopharma Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
